Patents by Inventor Jun Kudoh

Jun Kudoh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-tumor peptides and use thereof
    Patent number: 10829523
    Abstract: The anti-tumor peptide provided by the present invention is a synthetic peptide having both amino acid sequences represented by the following (1) and (2): (1) an amino acid sequence constituting the transmembrane domain of transmembrane protein 141 (TMEM 141), or a modified amino acid sequence having deletion, replacement, or addition of one, two, or three amino acid residues of the amino acid sequence; and (2) an amino acid sequence functioning as a cell membrane penetrating peptide (CPP).
    Type: Grant
    Filed: November 16, 2017
    Date of Patent: November 10, 2020
    Assignees: Keio University, National University Corporation Nagoya, Toagosei Co., Ltd.
    Inventors: Nahoko Baileykobayashi, Tetsuhiko Yoshida, Makoto Sawada, Jun Kudoh, Tamami Adachi, Yasuhiro Tonoyama
  • ANTI-TUMOR PEPTIDES AND USE THEREOF
    Publication number: 20180141985
    Abstract: The anti-tumor peptide provided by the present invention is a synthetic peptide having both amino acid sequences represented by the following (1) and (2): (1) an amino acid sequence constituting the transmembrane domain of transmembrane protein 141 (TMEM 141), or a modified amino acid sequence having deletion, replacement, or addition of one, two, or three amino acid residues of the amino acid sequence; and (2) an amino acid sequence functioning as a cell membrane penetrating peptide (CPP).
    Type: Application
    Filed: November 16, 2017
    Publication date: May 24, 2018
    Inventors: Nahoko Baileykobayashi, Tetsuhiko Yoshida, Makoto Sawada, Jun Kudoh, Tamami Adachi, Yasuhiro Tonoyama
  • Gene defective in APECED and its use
    Patent number: 7785789
    Abstract: The present invention relates to a method for the diagnosis of a disease related to immune maturation and regulation of immune response towards self and nonself, comprising the steps of detecting in a biological specimen the presence of a DNA sequence comprising the sequence of SEQ ID NO:1.
    Type: Grant
    Filed: August 10, 2006
    Date of Patent: August 31, 2010
    Assignee: Finnish Immunotechnology Ltd.
    Inventors: Kai Krohn, Maarit Heino, Pärt Peterson, Hamish S Scott, Stylianos E. Antonarakis, Maria D. Lalioti, Nobuyoshi Shimizu, Jun Kudoh
  • Gene defective in APECED and its use
    Patent number: 7217806
    Abstract: The present invention relates to a novel gene, a novel protein encoded by said gene, a mutated form of the gene and to diagnostic and therapeutic uses of the gene or a mutated form thereof. More specifically, the present invention relates to a novel gene defective in autoimmune polyendocrinopathy syndrome type I (APS I), also called autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) (MIM No. 240,300).
    Type: Grant
    Filed: September 23, 1998
    Date of Patent: May 15, 2007
    Assignee: Finnish Immunotechnology Ltd.
    Inventors: Kai Krohn, Maarit Heino, Pärt Peterson, Hamish Scott, Stylianos Antonarakis, Maria Lalioti, Nobuyoshi Shimizu, Jun Kudoh
  • Novel gene defective in APECED and its use
    Publication number: 20070020674
    Abstract: The present invention relates to a method for the diagnosis of a disease related to immune maturation and regulation of immune response towards self and nonself, comprising the steps of detecting in a biological specimen the presence of a DNA sequence comprising the sequence of SEQ ID NO:1.
    Type: Application
    Filed: August 10, 2006
    Publication date: January 25, 2007
    Inventors: Kai Krohn, Maarit Heino, Part Peterson, Hamish Scott, Stylianos Antonarakis, Maria Lalioti, Nobuyoshi Shimizu, Jun Kudoh